Impact of innate immunity in a subset of children with autism spectrum disorders: a case control study
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Among patients with autism spectrum disorders (ASD) evaluated in our clinic, there appears to be a subset that can be clinically distinguished from other ASD children because of frequent infections (usually viral) accompanied by worsening behavioural symptoms and/or loss/decrease in acquired skills. This study assessed whether these clinical features of this ASD subset are associated with atopy, asthma, food allergy (FA), primary immunodeficiency (PID), or innate immune responses important in viral infections. METHODS: This study included the ASD children described above (ASD test, N = 26) and the following controls: ASD controls (N = 107), non-ASD controls with FA (N = 24), non-ASD controls with chronic rhinosinusitis/recurrent otitis media (CRS/ROM; N = 38), and normal controls (N = 43). We assessed prevalence of atopy, asthma, FA, CRS/ROM, and PID. Innate immune responses were assessed by measuring production of proinflammatory and counter-regulatory cytokines by peripheral blood mononuclear cells (PBMCs) in response to agonists of Toll-like receptors (TLRs), with or without pre-treatment of lipopolysaccharide (LPS), a TLR4 agonist. RESULTS: Non-IgE mediated FA was equally prevalent in both ASD test and ASD control groups, occurring at higher frequency than in the non-ASD controls. Allergic rhinitis, atopic/non-atopic asthma, and atopic dermatitis were equally prevalent among the study groups except for the CRS/ROM group in which non-atopic asthma was more prevalent (52.6%). CRS/ROM and specific polysaccharide antibody deficiency (SPAD) were more prevalent in the ASD test group than in the ASD control, FA, and normal control groups: 23.1% vs. < 5% for CRS/ROS and 19.2% vs. < 1% for SPAD. However, CRS/ROM patients had the highest prevalence of SPAD (34.2%). When compared to ASD and normal case controls, PBMCs from 19 non-SPAD, ASD test group children produced: 1) less IL-1beta with a TLR7/8 agonist, less IL-10 with a TLR2/6 agonist, and more IL-23 with a TLR4 agonist without LPS pre-treatment, and 2) less IL-1beta with TLR4/7/8 agonists with LPS pre-treatment. These are cytokines associated with the neuro-immune network. CONCLUSION: Clinical features of the ASD test group were not associated with atopy, asthma, FA, or PID in our study but may be associated with altered TLR responses mediating neuro-immune interactions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuroglial activation and neuroinflammation in the brain of patients with autism
Vargas, D. L., Nascimbene, C., Krishnan, C., Zimmerman, A. W., & Pardo, C. A. (2005) · Annals of Neurology · doi:10.1002/ana.20315 · Cited by 2,149 · cited 1×
“Interestingly, the presence of low-grade chronic inflammation has been reported in brain tissue of individuals with autism [20,21].”
BackgroundPace, T. W. W., Hu, F., & Miller, A. H. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2006.08.009 · Cited by 621
The immune response in autism: a new frontier for autism research
Ashwood, P., Wills, S., & Van de Water, J. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.1205707 · Cited by 528 · cited 1×
“Moreover, reported results are conflicting; some studies indicate type 1 T-helper (Th1)skewed responses while other studies indicate Th2skewed responses [13-16].”
ResultAkdis, C. A., Akdis, M., Bieber, T., Bindslev-Jensen, C., Boguniewicz, M., Eigenmann, P., Hamid, Q., Kapp, A., Leung, D. Y. M., Lipozencic, J., et al. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.03.045 · Cited by 460
How environmental and genetic factors combine to cause autism: A redox/methylation hypothesis
Deth, R., Muratore, C., Benzecry, J., Power-Charnitsky, V.-A., & Waly, M. (2008) · NeuroToxicology · doi:10.1016/j.neuro.2007.09.010 · Cited by 325 · cited 2×
“The 'redux/methylation hypothesis' postulates that environmental factors and genetic factors play pathogenic roles in some autistic children [17].”
BackgroundJyonouchi, H., Sun, S., & Itokazu, N. (2002) · Neuropsychobiology · doi:10.1159/000065416 · Cited by 225
Self-citationJyonouchi, H., Geng, L., Ruby, A., & Zimmerman-Bier, B. (2005) · Neuropsychobiology · doi:10.1159/000084164 · Cited by 201 · cited 1×
“In these ASD children with NFA, we also observed excessive production of TNF-α in response to LPS, an agonist of Toll-like receptor 4 (TLR4) [3].”
BackgroundSelf-citationIs autism an autoimmune disease?
Ashwood, P., & Van de Water, J. (2004) · Autoimmunity Reviews · doi:10.1016/j.autrev.2004.07.036 · Cited by 181
Interleukin‐1 in the Brain: Mechanisms of Action in Acute Neurodegeneration
PATEL, H. C., BOUTIN, H., & ALLAN, S. M. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb03136.x · Cited by 139
Cited by
Altered T cell responses in children with autism
Ashwood, P., Krakowiak, P., Hertz-Picciotto, I., Hansen, R., Pessah, I. N., & Van de Water, J. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.09.002 · Cited by 281
Muskens, J. B., Velders, F. P., & Staal, W. G. (2017) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-017-1020-0 · Cited by 232
“…1 Autism spectrum disorders and medical disorders Authors Year Study size cases/controls Age range (years) Study design Medical disorder Immunology Jyonouchi et al. 2008 26/212 1–18 Cross-sectional Atopy, asthma, allergy and immunodeficiency MH Chen et al. 2014 14,812/6994 1–14 Case–control…”
BackgroundInfluentialLow-grade endotoxemia in patients with severe autism
Emanuele, E., Orsi, P., Boso, M., Broglia, D., Brondino, N., Barale, F., di Nemi, S. U., & Politi, P. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.01.033 · Cited by 225
Immune Dysregulation in Autism Spectrum Disorder: What Do We Know about It?
Robinson-Agramonte, M. D. L. A., Noris García, E., Fraga Guerra, J., Vega Hurtado, Y., Antonucci, N., Semprún-Hernández, N., Schultz, S., & Siniscalco, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063033 · Cited by 176
Parker-Athill, E. C., & Tan, J. (2010) · Neurosignals · doi:10.1159/000319828 · Cited by 140
Metadata
- Authors
- Jyonouchi, H., Geng, L., Cushing-Ruby, A., & Quraishi, H.
- Venue
- Journal of Neuroinflammation
- Published
- 2008
- Volume
- 5
- Issue
- 1
- Pages
- 52
- ISSN
- 1742-2094 (ISSN-L)
- OpenAlex
- W2128503836
- Cited by
- 111
- References
- 9
- FWCI
- 4.22
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Impact of innate immunity in a subset of children with autism spectrum disorders: a case control study. https://app.cochat.ai/papers/10.1186/1742-2094-5-52
- The paper
- Jyonouchi, H., Geng, L., Cushing-Ruby, A., & Quraishi, H. (2008). Impact of innate immunity in a subset of children with autism spectrum disorders: a case control study. Journal of Neuroinflammation. https://doi.org/10.1186/1742-2094-5-52
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.